Lu Yongtao
chairmain @ Hengxu Capital
Jiading, China
Lu Yongtao is a chairman at hengxu capital. He was in charge of the overall listing of SAIC Group, and has been in charge of the capital operation of SAIC Group for a long time.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 92%
Last updated:
For AI agents: llms.txt
Industries Lu Yongtao invests in
Stages Lu Yongtao invests in
Countries Lu Yongtao invests in
Investment Focus
Industry
- Health Care 8 (62%)
- Medical 7 (54%)
- Biotechnology 5 (38%)
- Biopharma 3 (23%)
- B2B 1 (8%)
Stage
- Series A 4 (31%)
- Series B 4 (31%)
- Seed 2 (15%)
- Angel 1 (8%)
- Series C 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TsIntergy Technology
|
TsIntergy Technology is a national high-tech enterprise focusing on energy industry operations optimization and artificial intelligence applications.We are mainly engaged in the construction of electric power market, optimization of power grid dispatching, digitalization and intelligent operation of power generation, energy internet planning andoperation optimization, energy big data analysis and prediction, etc. Customers provide products and services such as strategic consulting, core algorithms, software platforms, cloud platform applications, information mining and analysis | $27.4M / Venture - Series Unknown / Apr 21, 2025 | |
Sainte
|
Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs | $54.9M / Series B / Feb 27, 2025 | |
Wisbiom
|
Wisbiom is a microbiotherapy company that specializes in the development of microecological preparations, living biopharmaceuticals (LBP), and microbiome-related products and solutions to better serve human health. | $1.4M / Seed / Dec 18, 2023 | |
Xingsai Bio
|
Xingsai Bio is a developer of single-cell analysis instruments and supporting reagents and consumables. | $13.9M / Series A / Dec 12, 2023 | |
Cataya Bio
|
Cataya Bio (Shanghai) Co., Ltd. is a product company powered by an advanced engineering biology platform and biomanufacturing. We engineer microbes and develop clean fermentation processes to manufacture products of high purity, at low cost, and in a sustainable way. We strive to help the world to transition away from petroleum and addressimportant global issues in environmental preservation, carbon emission and climate change. | $34.4M / Series B / Sep 04, 2023 | |
Protoga
|
Yuan Yu Bio is a biotech firm that focused on the development of innovative microalgae biosynthesis technology. | $13.7M / Series A / Aug 16, 2023 | |
Levostar
|
Levostar is a biotechnology company that specializes in the development and manufacture of cell and gene therapy products. | Seed / Jun 27, 2023 | |
ZD Medtech
|
Zhuo Dao Medical has a domestic R&D team of rehabilitation robots dedicated to providing world-leading robotic assistive technology and intelligent rehabilitation solutions for clinical rehabilitation. With rich training mode, excellent human-computer interaction and intelligent rehabilitation management system, Zhuo Dao Medical is adapting tothe needs of Chinese rehabilitation medicine through continuous accumulation and continuous innovation in the field of rehabilitation engineering, and promoting the rapid development of rehabilitation medicine. . | $14.6M / Series B / Feb 15, 2023 | |
Yudao Bio
|
Yudo Bio provides biopharmaceutical products. It has its headquarters in Shanghai in China. | $40M / Series A / Mar 14, 2022 | |
Xgene Pharmaceutical
|
Xgene Pharmaceutical is a pharmaceutical company. | $40M / Series C / Nov 05, 2021 | |
| See all 13 investments → | |||
Co-Investors
Bits x Bites
1 deal together
Cathay Capital
1 deal together
CITIC Securities
1 deal together
Eight Roads Ventures
1 deal together
ELIM Capital
1 deal together
About Hengxu Capital
Hengxu Capital is an investment firm.
Hengxu Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Lu Yongtao
chairmain
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Lu Yongtao invest in?
Lu Yongtao invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 13 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Lu Yongtao last invest?
The most recent investment recorded for Lu Yongtao closed in Apr 2025. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
